No Data
No Data
CSPC Innovation Pharmaceutical (300765.SZ): Enbipu Pharmaceuticals has cumulatively increased its shareholding by 0.24%.
Gelonghui, May 8th | CSPC Innovation Pharmaceutical (300765.SZ) announced that as of the date of this announcement, the shareholding plan by Enbipu Pharmaceutical has been fully implemented. From November 8, 2024, to May 7, 2025, Enbipu Pharmaceutical has cumulatively increased its shareholding in the company by 3,313,900 shares through the trading system of the Shenzhen Exchange via centralized bidding, accounting for 0.24% of the company's total shares (excluding the number of shares calculated from the latest disclosed repurchase account, similar hereafter), with a total increase amount of 103,019,003.53 yuan (excluding handling fees).
Express News | Dahua Jixian: Downgraded the rating of Shineway Pharmaceutical Holdings Limited to Sell.
Express News | CSPC Innovation Pharmaceutical: Termination of the issuance of shares and payment of Cash / Money Market to purchase Assets.
Significant pullback! The Innovative Drugs Sector of the Hong Kong stock market was suddenly hit by a "air raid"! What happened?
The Hong Kong stock market's Innovative Drugs Sector is experiencing a high-level adjustment.
CSPC Innovation Pharmaceutical Swings to Q1 Loss
CSPC Innovation Pharmaceutical: 2025 First Quarter Report